The Clorox Company (NYSE:CLX) Shares Sold by Mitchell Mcleod Pugh & Williams Inc.

Mitchell Mcleod Pugh & Williams Inc. cut its holdings in shares of The Clorox Company (NYSE:CLX) by 12.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,942 shares of the company’s stock after selling 567 shares during the period. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Clorox were worth $640,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CLX. Brooklyn Investment Group boosted its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in Clorox in the third quarter worth about $27,000. Continuum Advisory LLC grew its position in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares in the last quarter. Quarry LP increased its stake in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox during the 3rd quarter worth about $48,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Down 0.1 %

CLX stock opened at $160.31 on Monday. The company’s 50 day simple moving average is $164.25 and its 200-day simple moving average is $156.54. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm has a market capitalization of $19.84 billion, a P/E ratio of 55.86, a P/E/G ratio of 2.90 and a beta of 0.42.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.49 earnings per share. As a group, equities research analysts anticipate that The Clorox Company will post 6.87 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. Clorox’s payout ratio is presently 170.04%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on CLX shares. Barclays dropped their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday. JPMorgan Chase & Co. boosted their price objective on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.